How EY Entrepreneur Of The Year 2021 Winner AbCellera is Building a Biotech Powerhouse

Canada has a strong track record of medical innovation: insulin, stem-cell therapies and HIV drug cocktails all have their origins in this country. However, life-saving innovation has been limited in recent years with a lack of funding coming from within our borders.

“We haven’t seen the growth of the really global, at-scale companies for this industry,” says Carl Hansen, chief executive officer of AbCellera Biologics Inc. “I think it’s conspicuous that if you look across the G7, we’re the only country without a fully integrated global biopharmaceutical company.”

Dr. Hansen, selected as Canada’s EY Entrepreneur Of The Year® in November, is on a mission to change that with his Vancouver-based technology company.

“It’s easy for innovation to get curbed in today’s complex regulatory landscape coupled with increasing research and developments costs,” says Paula Smith, EY Entrepreneur Of The Year Canada program director.

Read the full article here.